Stephen Mandel Fate Therapeutics Inc Put Options Transaction History
Lone Pine Capital LLC
- $12.7 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FATE
# of Institutions
178Shares Held
124MCall Options Held
222KPut Options Held
48.6K-
Redmile Group, LLC San Francisco, CA13.2MShares$42.9 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.91MShares$32.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$29.7 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA8.22MShares$26.8 Million3.14% of portfolio
-
State Street Corp Boston, MA8.04MShares$26.2 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $316M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...